NYSE · Healthcare · Medical Devices · USA
Conmed Corp is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
CONMED is a medical technology company that manufactures and distributes surgical devices and equipment used by healthcare professionals in orthopedic surgery and general surgery. The company offers orthopedic products including soft tissue fixation systems and powered instruments, alongside general surgery offerings featuring insufflation systems and endoscopic technologies. CONMED distributes its products worldwide through manufacturing locations and international sales operations.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Conmed Corp stock.
Overvalued: intrinsic value $24.92 per share, market price $47.58, margin of safety -90.9% (as of 2026-10-20).
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $24.92; the price of $47.58 is 91% above that value, and 79% of that value comes from beyond year five.
Leak Score: 48/100 on 12 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
35 more in this industry show a wider margin of safety.
CNMD is overvalued (as of the 2026-10-20 close). Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $24.92; the price of $47.58 is 91% above that value, and 79% of that value comes from beyond year five.
$24.92 per share (as of the 2026-10-20 close), against a market price of $47.58. That is a margin of safety of -90.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
48 out of 100, which we rate "On Watch", on 12 of 12 value investing signals.